These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 10085027)

  • 1. Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells.
    Singh Y; Klimpel KR; Goel S; Swain PK; Leppla SH
    Infect Immun; 1999 Apr; 67(4):1853-9. PubMed ID: 10085027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of the Bacillus anthracis 20 kDa protective antigen component.
    Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
    BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both PA63 and PA83 are endocytosed within an anthrax protective antigen mixed heptamer: a putative mechanism to overcome a furin deficiency.
    Chekanov AV; Remacle AG; Golubkov VS; Akatov VS; Sikora S; Savinov AY; Fugere M; Day R; Rozanov DV; Strongin AY
    Arch Biochem Biophys; 2006 Feb; 446(1):52-9. PubMed ID: 16384550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen.
    Mogridge J; Cunningham K; Lacy DB; Mourez M; Collier RJ
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7045-8. PubMed ID: 11997437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthrax toxin.
    Bhatnagar R; Batra S
    Crit Rev Microbiol; 2001; 27(3):167-200. PubMed ID: 11596878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding of lethal factor to PA63: as determined by trNOESY NMR and molecular modeling.
    Hicks RP; Bhattacharjee AK; Koser BW; Traficante DD
    J Med Chem; 2004 Oct; 47(22):5347-55. PubMed ID: 15481973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular model of anthrax toxin translocation into target-cells].
    Noskov AN
    Bioorg Khim; 2014; 40(4):399-404. PubMed ID: 25898749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-association of the transmembrane domain of an anthrax toxin receptor.
    Go MY; Kim S; Partridge AW; Melnyk RA; Rath A; Deber CM; Mogridge J
    J Mol Biol; 2006 Jun; 360(1):145-56. PubMed ID: 16756998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor.
    Singh Y; Klimpel KR; Arora N; Sharma M; Leppla SH
    J Biol Chem; 1994 Nov; 269(46):29039-46. PubMed ID: 7961869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of a complex between anthrax toxin and its host cell receptor.
    Santelli E; Bankston LA; Leppla SH; Liddington RC
    Nature; 2004 Aug; 430(7002):905-8. PubMed ID: 15243628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethal factor of anthrax toxin binds monomeric form of protective antigen.
    Chvyrkova I; Zhang XC; Terzyan S
    Biochem Biophys Res Commun; 2007 Aug; 360(3):690-5. PubMed ID: 17617379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic activation of receptor-bound anthrax protective antigen on macrophages promotes its internalization.
    Beauregard KE; Collier RJ; Swanson JA
    Cell Microbiol; 2000 Jun; 2(3):251-8. PubMed ID: 11207581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity.
    Panchal RG; Halverson KM; Ribot W; Lane D; Kenny T; Abshire TG; Ezzell JW; Hoover TA; Powell B; Little S; Kasianowicz JJ; Bavari S
    J Biol Chem; 2005 Mar; 280(11):10834-9. PubMed ID: 15644338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of amino acid residues of anthrax protective antigen involved in binding with lethal factor.
    Chauhan V; Bhatnagar R
    Infect Immun; 2002 Aug; 70(8):4477-84. PubMed ID: 12117959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of membrane translocation by anthrax protective antigen.
    Wesche J; Elliott JL; Falnes PO; Olsnes S; Collier RJ
    Biochemistry; 1998 Nov; 37(45):15737-46. PubMed ID: 9843379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The channel formed in planar lipid bilayers by the protective antigen component of anthrax toxin.
    Finkelstein A
    Toxicology; 1994 Feb; 87(1-3):29-41. PubMed ID: 7512762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dominant negative mutant of Bacillus anthracis protective antigen inhibits anthrax toxin action in vivo.
    Singh Y; Khanna H; Chopra AP; Mehra V
    J Biol Chem; 2001 Jun; 276(25):22090-4. PubMed ID: 11278644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthrax protective antigen forms oligomers during intoxication of mammalian cells.
    Milne JC; Furlong D; Hanna PC; Wall JS; Collier RJ
    J Biol Chem; 1994 Aug; 269(32):20607-12. PubMed ID: 8051159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton-coupled protein transport through the anthrax toxin channel.
    Finkelstein A
    Philos Trans R Soc Lond B Biol Sci; 2009 Jan; 364(1514):209-15. PubMed ID: 18957378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthrax protective antigen cleavage and clearance from the blood of mice and rats.
    Moayeri M; Wiggins JF; Leppla SH
    Infect Immun; 2007 Nov; 75(11):5175-84. PubMed ID: 17724066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.